DNA X Statistics
Total Valuation
DNA X has a market cap or net worth of $4.66 million. The enterprise value is $6.16 million.
| Market Cap | 4.66M |
| Enterprise Value | 6.16M |
Important Dates
The last earnings date was Wednesday, August 19, 2026, after market close.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DNA X has 1.49 million shares outstanding. The number of shares has increased by 233.44% in one year.
| Current Share Class | 1.49M |
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | +233.44% |
| Shares Change (QoQ) | +6.79% |
| Owned by Insiders (%) | 10.06% |
| Owned by Institutions (%) | 9.11% |
| Float | 1.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.06 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.66% |
| Return on Invested Capital (ROIC) | -275.50% |
| Return on Capital Employed (ROCE) | 959.02% |
| Weighted Average Cost of Capital (WACC) | 23.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.14M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.50% in the last 52 weeks. The beta is 1.86, so DNA X's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | -69.50% |
| 50-Day Moving Average | 3.62 |
| 200-Day Moving Average | 4.46 |
| Relative Strength Index (RSI) | 40.72 |
| Average Volume (20 Days) | 8,347 |
Short Selling Information
The latest short interest is 26,029, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 26,029 |
| Short Previous Month | 59,407 |
| Short % of Shares Out | 1.75% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 1.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.06M |
| Pretax Income | -10.30M |
| Net Income | -8.55M |
| EBITDA | -3.48M |
| EBIT | -6.06M |
| Earnings Per Share (EPS) | -$7.35 |
Balance Sheet
The company has $900,000 in cash and $2.40 million in debt, with a net cash position of -$1.50 million or -$1.01 per share.
| Cash & Cash Equivalents | 900,000 |
| Total Debt | 2.40M |
| Net Cash | -1.50M |
| Net Cash Per Share | -$1.01 |
| Equity (Book Value) | -1.23M |
| Book Value Per Share | -0.83 |
| Working Capital | -2.23M |
Cash Flow
| Operating Cash Flow | -14.51M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.58M |
| Net Borrowing | 5.42M |
| Free Cash Flow | -14.51M |
| FCF Per Share | -$9.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DNA X does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -233.44% |
| Shareholder Yield | -233.44% |
| Earnings Yield | -183.48% |
| FCF Yield | -311.38% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 27, 2025. It was a reverse split with a ratio of 1:18.
| Last Split Date | Oct 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |